IL17A and myeloid sarcoma: In addition, CD161highCCR6+γδ T cells release IL-17 that may play a part in the localized inflammatory reaction in the CNS of MS subjects given that its distribution in the CSF of people with CIS/MS in relapse is considerably greater [313].